Equities

Laurus Labs Ltd

LAURUSLABS:NSI

Laurus Labs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)436.95
  • Today's Change11.05 / 2.59%
  • Shares traded8.55m
  • 1 Year change+45.72%
  • Beta1.5140
Data delayed at least 15 minutes, as of Apr 26 2024 11:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • LAURUSLABS:NSI reported earnings of 1.40 for the period of the year 2024Q4.
  • LAURUSLABS:NSI trading volume exceeds daily average by +108.84%
  • LAURUSLABS:NSI price moved over +1.01% to 430.80
  • LAURUSLABS:NSI price rises above 15-day moving average to 443.05 at 15:46 BST
  • LAURUSLABS:NSI price rises above 15-day moving average to 438.20 at 12:32 BST
  • LAURUSLABS:NSI price rises above 15-day moving average to 434.75 at 10:16 BST
  • LAURUSLABS:NSI price rises above 15-day moving average to 432.50 at 14:05 BST

Key statistics

On Friday, Laurus Labs Ltd (LAURUSLABS:NSI) closed at 436.95, -7.23% below its 52-week high of 471.00, set on Apr 10, 2024.
52-week range
Today
278.85Apr 28 2023471.00Apr 10 2024
Open420.20
High443.85
Low414.60
Bid436.95
Offer436.95
Previous close425.90
Average volume2.97m
Shares outstanding538.97m
Free float352.54m
P/E (TTM)122.53
Market cap229.55bn INR
EPS (TTM)3.48
INR
Annual div (ADY)1.60
INR
Annual div yield (ADY)0.38%
Div ex-dateNov 02 2023
Div pay-dateNov 09 2023
Data delayed at least 15 minutes, as of Apr 26 2024 11:26 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.